Composition – DICYCLOMINE HYDROCHLORIDE 10 MG + ACTIVATED DIMETHICONE 40MG
Dosage Form – DROPS
Packaging – 10ML
Megicospas Drops is a pediatric antispasmodic and anti-flatulent medicine used to relieve abdominal pain, cramps, and gas in infants and children. It helps soothe the stomach and provides quick relief from colic-like discomfort.
Megicospas Drops is a pediatric formulation containing a combination of Dicyclomine Hydrochloride (10 mg) and Activated Dimethicone (40 mg). This dual-action formula helps relax intestinal muscles and reduce trapped gas, making it effective for managing abdominal cramps, colic, and bloating in children.
Megicospas drops are used to :
1) Relieve abdominal discomfort.
2) Reduce infantile colic.
3) Alleviate gas, bloating and flatulence.
4) Ease discomfort due to intestinal spasms.
Megicospas drops are usually well tolerated. However, some possible side effects may include: Dry mouth, Drowsiness, Mild constipation and Diarrhea.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a marked dropper and take it as directed. Megicospas Drop may be taken with or without food.
Megicospas Drops work through a dual mechanism. Dicyclomine relaxes the smooth muscles of the gut, reducing painful spasms and cramps, while Activated Dimethicone breaks down gas bubbles in the stomach and intestines, helping relieve bloating and discomfort. Together, they provide fast and effective relief from abdominal pain and colic in children.
| Habit Forming | No |
|---|---|
| Therapeutic Class | Gastrointestinal |
1) Use the measuring dropper for accurate dosing.
2) Give your child a diet that is rich in fiber and low in fermentable sugars.
3) Do not exceed the recommended dosage.
Give the missed dose as soon as you remember. If it is close to the next dose, skip the missed dose. Do not double the dose.
Megicospas drops are used to relieve abdominal discomfort, infantile colic and in the treatment of irritable bowel syndrome.
The above-mentioned symptoms may indicate abdominal migraine which is characterized by recurrent episodes of dull and moderate to severe intensity abdominal pain for at least six months. It typically occurs in the midline or is poorly localized. Abdominal pain is associated with additional features including anorexia, nausea, vomiting, headache, photophobia, and pallor. Do rule out such types of pain before giving Megicospas drops.
The doctor may advise abdominal ultrasound for a routine examination. In serious abdominal conditions, endoscopy and esophageal pH may also be monitored.
DROPS